SCHEMBL20370689

SCHEMBL20370689

O=P(c1ccccc1)(c1ccccc1)c1cccc(-c2ccc3c(c2)Sc2nc4ccccc4nc2S3)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.33
▸ HDAC1 Q13547 1/20 0.32
▸ PIK3CA P42336 2/20 0.32
▸ PI4KA P42356 1/20 0.32
▸ PI4KB Q9UBF8 1/20 0.32
▸ PTPN2 P17706 2/20 0.32
▸ PTPN1 P18031 2/20 0.32
▸ PTPRC P08575 1/20 0.32
▸ FBP1 P09467 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.31
▸ LDHA P00338 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ SCD O00767 1/20 0.30
▸ GRM5 P41594 1/20 0.30
▸ PTPN4 P29074 1/20 0.30
▸ PTPN9 P43378 1/20 0.30
▸ PTPN11 Q06124 1/20 0.30
▸ PIK3R1 P27986 1/20 0.30
▸ GGPS1 O95749 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370744 0.93 MAPT (0.35) MAPTHDAC1PIK3CAPI4KAPI4KB
SCHEMBL20370721 0.90 PIK3CA (0.38) HDAC1PIK3CAPI4KAPI4KBFBP1
SCHEMBL20370704 0.88 MAPT (0.33) MAPTPTPN2PTPN1FBP1PTPN4
SCHEMBL20370693 0.88 MAPT (0.36) MAPTPTPN2PTPN1PTPN4PTPN9
SCHEMBL20370728 0.86 PIK3CA (0.38) PIK3CAPI4KAPI4KBBACE1PIK3R1
SCHEMBL20370670 0.86 PIK3CA (0.40) PIK3CAPI4KAPI4KBDHODHBACE1
SCHEMBL20370738 0.81 MAPT (0.31) MAPT
SCHEMBL20370680 0.80 MEN1 (0.40) MAPTPIK3CAPI4KAPI4KBBACE1
SCHEMBL20370688 0.80 TOP1 (0.32) MAPT
SCHEMBL20370736 0.79 MAPT (0.38) MAPTPTPN2PTPN1PTPN4PTPN9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-01 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CRY2, CYP1A1 MAPT 1408/4885HDAC1 560/4885PIK3CA 4290/4885
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CYP1A1 MAPT 1408/4885HDAC1 560/4885PIK3CA 4290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback